TREATMENT OF ASTRAZENECA – (11-03-03)



The statin wars: why AstraZeneca must retreat

If you would like a small peek into the complex and powerful realm of pharmaceutical manufacturing and marketing, this editorial should give you a taste. We begin to see how data is manipulated around not for the patient’s benefit, but rather for the bottom line of the shareholders.

The Journal : Back Issues.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Miscellaneous
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”